River 3 Renal Corp.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease. (NCT06600412) | River 3 Renal Corp. | 2024-10-10 |
| Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis (NCT05267262) | River 3 Renal Corp. | 2022-06-15 |
Track River 3 Renal Corp. automatically
Every clearance here is in the API, with alerts when new ones post.